Oral Session 3-7A Multiple Myeloma: Daratumumab

[OS3-7A-3] Daratumumab/lenalidomide/dexamethasone (D-Rd) in transplant-ineligible NDMM: impact of age in MAIA

Nizar J. Bahlis¹, Saad Z. Usmani², Thierry Facon³, Shaji Kumar⁴, Torben Plesner⁵, Philippe Moreau⁶, Supratik Basu⁷, Hareth Nahi⁸, Margaret Macro⁹, Hang Quach¹⁰, Aurore Perrot¹¹, Christopher P. Venner¹², Katja Weisel¹³, Noopur Raje¹⁴, Michel Attal¹⁵, Xavier Leleu¹⁶, Maria Krevvata¹⁷, Jianping Wang¹⁸, Rachel Kobos¹⁸, Cyrille Hulin¹⁹ (1.University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada, 2.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America, 3.Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France Metropolitan, 4.Department of Hematology, Mayo Clinic Rochester, Rochester, MN, United States of America, 5.Vejle Hospital and University of Southern Denmark, Vejle, Kingdom of Denmark, 6.Hematology, University Hospital Hôtel-Dieu, Nantes, France Metropolitan, 7.Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom of Great Britain and Northern Ireland, 8.Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Kingdom of Sweden, 9.Centre Hospitalier Universitaire (CHU) de Caen, Caen, France Metropolitan, 10.St. Vincent's Hospital, University of Melbourne, Melbourne, Australia, 11.Hematology Department, University Hospital, Vandoeuvre Les Nancy, France Metropolitan, 12.Division of Medical Oncology University of Alberta, Edmonton, AB, Canada, 13.Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Federal Republic of Germany, 14.Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, United States of America, 15.Service d'Hématologie, CHU de Toulouse-Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France Metropolitan, 16.Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France Metropolitan, 17.Janssen Research & Development, Spring House, PA, United States of America, 18.Janssen Research & Development, Raritan, NJ, United States of America, 19.Department of Hematology, Hospital Haut Leveque, University Hospital, Pessac, France Metropolitan)